CD274 and neoplasm: Researchers have proposed four distinct types of tumor immune microenvironment (TIME) based on factors such as tumor-infiltrating lymphocytes and PD-L1 expression, which could help design optimized immunotherapy or combination treatment strategies (51, 65).